(1S,3R)-3-氨基环戊醇盐酸盐
|
K036734-100mg
|
97% |
1259436-59-3 |
100mg
|
¥ 1371.0
|
5-7天 |
科威 |
(1S,3R)-3-氨基环戊醇盐酸盐
|
K036734-25mg
|
97% |
1259436-59-3 |
25mg
|
¥ 571.0
|
5-7天 |
科威 |
1-(4-氨基苯基)环丁基氨基甲酸叔丁酯
|
K036733-100mg
|
96% |
1259224-00-4 |
100mg
|
¥ 702.0
|
5-7天 |
科威 |
1-(4-氨基苯基)环丁基氨基甲酸叔丁酯
|
K036733-25mg
|
96% |
1259224-00-4 |
25mg
|
¥ 292.0
|
5-7天 |
科威 |
6-(4-氯苯基)吡嗪-2-甲酸
|
K036732-1g
|
95% |
1258850-50-8 |
1g
|
¥ 3566.0
|
5-7天 |
科威 |
6-(4-氯苯基)吡嗪-2-甲酸
|
K036732-250mg
|
95% |
1258850-50-8 |
250mg
|
¥ 1617.0
|
5-7天 |
科威 |
(11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-1-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
|
K036731-100mg
|
≥98%,99%e.e. |
1258327-08-0 |
100mg
|
¥ 5403.0
|
5-7天 |
科威 |
(11aS)-3,7-Bis[3,5-bis(trifluoromethyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
|
K036730-100mg
|
≥98%,99%e.e. |
1258327-07-9 |
100mg
|
¥ 5197.0
|
5-7天 |
科威 |
(11aS)-3,7-Bis([1,1'-biphenyl]-4-yl)-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
|
K036729-100mg
|
≥98%,99%e.e. |
1258327-06-8 |
100mg
|
¥ 5505.0
|
5-7天 |
科威 |
(11aS)-3,7-Bis([1,1'-biphenyl]-4-yl)-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
|
K036729-50mg
|
≥98%,99%e.e. |
1258327-06-8 |
50mg
|
¥ 3854.0
|
5-7天 |
科威 |
(11aS)-3,7-Bis(4-chlorophenyl)-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
|
K036728-100mg
|
≥95%,99%e.e. |
1258327-05-7 |
100mg
|
¥ 5011.0
|
5-7天 |
科威 |
(11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-diphenyl-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
|
K036727-100mg
|
≥98%,99%e.e. |
1258327-04-6 |
100mg
|
¥ 4899.0
|
5-7天 |
科威 |
(S)-螺环二酚膦酸酯
|
K036726-100mg
|
≥98%,99%e.e. |
1258327-03-5 |
100mg
|
¥ 1399.0
|
5-7天 |
科威 |
(S)-2,2',3,3'-Tetrahydro-6,6'-di(1-naphthalenyl)-1,1'-spirobi[1H-indene]-7,7'-diol
|
K036725-100mg
|
≥98%,99%e.e. |
1258327-02-4 |
100mg
|
¥ 4211.0
|
5-7天 |
科威 |
(S)-6,6'-Bis[3,5-bis(trifluoromethyl)phenyl]-2,2',3,3'-tetrahydro-1,1'-spirobi[1H-indene]-7,7'-diol
|
K036724-100mg
|
≥98%,99%e.e. |
1258327-01-3 |
100mg
|
¥ 4078.0
|
5-7天 |
科威 |
(S)-6,6'-Bis([1,1'-biphenyl]-4-yl)-2,2',3,3'-tetrahydro-1,1'-spirobi[1H-indene]-7,7'-diol
|
K036723-100mg
|
≥98%,99%e.e. |
1258327-00-2 |
100mg
|
¥ 5571.0
|
5-7天 |
科威 |
(S)-6,6'-Bis(4-chlorophenyl)-2,2',3,3'-tetrahydro-1,1'spirobi[1H-indene]-7,7'-diol
|
K036722-100mg
|
≥98%,99%e.e. |
1258326-99-6 |
100mg
|
¥ 3761.0
|
5-7天 |
科威 |
(S)-2,2',3,3'-Tetrahydro-6,6'-diphenyl-1,1'-spirobi[1H-indene]-7,7'-diol
|
K036721-100mg
|
≥98%,99%e.e. |
1258326-98-5 |
100mg
|
¥ 3967.0
|
5-7天 |
科威 |
2,6-二氯-4-碘苯甲酸
|
K036720-250mg
|
98% |
1258298-01-9 |
250mg
|
¥ 2329.0
|
5-7天 |
科威 |
2,6-二氯-4-碘苯甲酸
|
K036720-50mg
|
98% |
1258298-01-9 |
50mg
|
¥ 776.0
|
5-7天 |
科威 |
5-溴-2-甲基吡啶-4-醇
|
K036719-50mg
|
97% |
1258287-39-6 |
50mg
|
¥ 926.0
|
5-7天 |
科威 |
1-(3-氟苯基)环己胺
|
K036718-1g
|
≥97% |
125827-86-3 |
1g
|
¥ 5707.0
|
5-7天 |
科威 |
1-(3-氟苯基)环己胺
|
K036718-250mg
|
≥97% |
125827-86-3 |
250mg
|
¥ 2021.0
|
5-7天 |
科威 |
(11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-bis[2,4,6-trisisopropylphenyl]-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
|
K036717-100mg
|
≥98%,99%e.e. |
1258276-28-6 |
100mg
|
¥ 6811.0
|
5-7天 |
科威 |